Maryland is taking a science-based approach to understanding and reducing the risk of PFAS exposure to Marylanders.
This page describes Maryland's actions to address PFAS in drinking water.
As information and data on PFAS continues to evolve, the following section provides an overview of each phase from our statewide PFAS in Public Drinking Water Study.
PFAS in Drinking Water Study:
In 2020, MDE-WSP began its multi-phase PFAS in Public Drinking Water Study in collaboration with the MDH-Laboratories Administration (MDH-LA). This study began as a way to help MDE understand the prevalence of PFAS contamination in its Public Water Systems (PWS) statewide. MDE-WSP is using this data to help water systems develop a plan for addressing PFAS in their systems with the goal that all Public Water Systems be in compliance with the PFAS Maximum Contaminant Levels (MCLs) by their effective date. In 2022, MDE completed sampling its Community Water Systems (CWS). We are currently in Phase 5 of our PFAS in Public Drinking Water Study.
Below is an interactive map of all publicly available sampling results from this study. If you would like to review this map and its features in its entirety, please visit the webpage linked here.
Below are links to our individual phase reports:
- Phase 1
- In September 2020, MDE initiated Phase 1 of the PFAS study to evaluate the occurrence of PFAS in PWS. During this phase, 129 Community Water Systems Water Treatment Plants (CWS-WTPs) were sampled and tested for all 18 PFAS analytes under EPA Method 537.1. Under Phase 1, approximately 13% of Maryland's federally regulated CWS's were monitored.
- Data (Excel or PDF)
- Phase 2
- As a result of the findings from Phase 1, MDE continued with Phase 2 of its PWS study from March through May 2021. Under Phase 2, 159 initial groundwater samples and eight (8) initial point of entry samples were collected. Under Phase 2, approximately 14% of Maryland's federally regulated CWS's were monitored.
- Data (Excel or PDF)
- Phase 3
- In August 2021, MDE initiated the third phase of its PWS study to evaluate the occurrence of PFAS in drinking water. During this phase, 759 drinking water samples were collected and tested for 18 PFAS under EPA Method 537.1. Samples collected under Phase 3 consisted of both finished and untreated water from a variety of groundwater sources withdrawing from confined, semi-confined, and unconfined aquifers, springs, and one surface water source.
- Data (Excel or PDF)
- Phase 4
- On June 15, 2022, the EPA released interim health advisories for PFOA and PFOS in drinking water at 0.004 parts per trillion (ppt) and 0.02 ppt, respectively. In response to these lowered levels, MDE initiated Phase 4 sampling, which looked at CWS's with previous detections of PFOA and PFOS (during Phases 1 through 3).
- Data (Excel or PDF)
- Phase 5 - Report in Progress
- In 2023, MDE initiated Phase 5 sampling which included Non-Transient Non-Community (NTNC) water systems. Sampling was completed in January 2025.
If you would like more information about these reports please contact the Water Supply Program at water.supply@maryland.gov.
Click on the below dropdowns for more information on PFAS in Drinking Water.